BJP College Seminars Series
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coppen, A.
Right arrow Articles by Armond, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coppen, A.
Right arrow Articles by Armond, A.

The British Journal of Psychiatry 139: 284-287 (1981)
© 1981 The Royal College of Psychiatrists

Lithium continuation therapy following electroconvulsive therapy

A Coppen, MT Abou-Saleh, P Milln, J Bailey, M Metcalfe, BH Burns and A Armond

Thirty-eight depressed patients who were treated with ECT were randomly assigned to receive lithium therapy or identical-looking placebo tablets for one year after clinical recovery in a double-blind trial. The patients who received placebo tablets spent an average of 7.8 weeks with an episode of depression (either as in-patients or day-patients) during the year. In comparison, patients who received lithium spent on average 1.7 weeks with an episode (P less than 0.02). The trial confirms the high rate of relapses after ECT and suggests that lithium considerably reduces this morbidity. It is suggested that ECT without continuation therapy is not a satisfactory treatment of depressive illness.


This article has been cited by other articles:


Home page
Am. J. PsychiatryHome page
A. Cipriani, H. Pretty, K. Hawton, and J. R. Geddes
Lithium in the Prevention of Suicidal Behavior and All-Cause Mortality in Patients With Mood Disorders: A Systematic Review of Randomized Trials
Am J Psychiatry, October 1, 2005; 162(10): 1805 - 1819.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
A. Coppen and C. Bolander-Gouaille
Treatment of depression: time to consider folic acid and vitamin B12
J Psychopharmacol, January 1, 2005; 19(1): 59 - 65.
[Abstract] [PDF]


Home page
JAMAHome page
H. A. Sackeim, R. F. Haskett, B. H. Mulsant, M. E. Thase, J. J. Mann, H. M. Pettinati, R. M. Greenberg, R. R. Crowe, T. B. Cooper, and J. Prudic
Continuation Pharmacotherapy in the Prevention of Relapse Following Electroconvulsive Therapy: A Randomized Controlled Trial
JAMA, March 14, 2001; 285(10): 1299 - 1307.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
E S Paykel
Continuation and maintenance therapy in depression
Br. Med. Bull., March 1, 2001; 57(1): 145 - 159.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
G. M. Goodwin
The effects of treatment on mortality in affective illness
J Psychopharmacol, January 1, 1992; 6(2_suppl): 312 - 317.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 1981 The Royal College of Psychiatrists.